POSTER SESSION II
Monday, March 22, 2010   —  1:00 PM - 4:30 PM
Exhibit Hall


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




BREAST PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
28 Morphologic Features of Breast Carcinoma Are Associated with False Negative Screening by Axillary Ultrasound (209)
TT Ha, S Charoenthammaraksa, C Liao, RA Schmidt, HA Sattar - University of Chicago, Chicago, IL
Add
29 Histologic Characteristics of Benign Breast Lesions Identified for Biopsy by Magnetic Resonance Imaging (231)
MM Johnson, V Dialani, NB Johnson - Massachusetts General Hospital, Boston, MA; Beth Israel Deaconess Medical Center, Boston, MA
Add
30 High Diagnostic Accuracy of FNAC Performed in a One Stop Clinic for the Diagnostic for Breast Lesions: A 3-Years Experience with 1822 Specimens (332)
P Vielh, I Borget, C Caramella, C Balleyguier, V Suciu, C Uzan, J Domont, M Mathieu, C Dromain, S Delaloge - Institut de Cancerologie Gustave Roussy, Villejuif, France
Add
31 Utility and Accuracy of Frozen Sections in Nipple Sparing Mastectomies (151)
RS Bains, WG Watkin - NorthShore University HealthSystem, Evanston, IL
Add
32 Coronal Serial Sectioning of Lumpectomy Specimens: Proposed Technique of Sectioning and Submission of Tissue for Microscopic Examination of Breast Carcinoma (141)
MS Amin, C Bicamampuka, J Swift, BF Burns, KT Mai - University of Ottawa, Ottawa, ON, Canada; The Ottawa Hospital, Ottawa, ON, Canada
Add
33 Flat Epithelial Atypia Is a Common Subtype of B3 Breast Lesions and Associated with Non-Invasive Cancer but Not with Invasive Cancer in Final Excision Histology (277)
A Noske, S Pahl, C Richter-Ehrenstein, E Fallenberg, AC Buckendahl, C Denkert - Universitatsspital Zurich, Zurich, Switzerland; Charite, Berlin, Germany
Add
34 Columnar Cell Lesions and Flat Epithelial Atypia in Breast Biopsies Performed Due to the Presence of Mammographic Suspicious Abnormalities (183)
M De Brot, CB Nunes, H Gobbi - Federal University of Minas Gerais - UFMG, Belo Horizonte, Minas Gerais, Brazil
Add
35 Columnar Cell Lesions of the Breast: Association with Other Types of Fibrocystic Change and Distribution in Hispanic and Non-Hispanic White Women (258)
L Lomo, M Myrsiades, A Nibbe, T Bocklage, D Hill - University of New Mexico School of Medicine, Albuquerque, NM
Add
36 ER+PR- Breast Carcinomas Are More Frequently Associated with Older Patients, Larger Tumors and HER2 Positive Tumors (325)
P Tai, J Wang, P Ding, P Tang - University of Rochester Medical Center, Rochester, NY; RTI Health Solutions, Research Triangle Park, NC
Add
37 Significance of Partial Reverse Cell Polarity in Breast Cancer - Part of a Spectrum of Micropapillary Carcinoma? (131)
G Acs, NN Esposito, Z Rakosy, C Laronga, PJ Zhang - Moffitt Cancer Center, Tampa, FL; Women's Pathology Consultants, Ruffolo Hooper & Associates, Tampa, FL; University of Pennsylvania Medical Center, Philadelphia, PA
Add
38 Infiltrative Epitheliosis of the Breast: Clinicopathological Review of Seven Cases of "A Pseudoinfiltrative Epitheliosis" (220)
MJ Horne, N Buza, FA Tavassoli - Yale-New Haven Hospital, New Haven, CT
Add
39 Primary Breast Malignant Fibrous Histiocytoma: A Clinicopathologic Review of 19 Cases with Two New Variants (212)
PH Hartel, G Bratthauer, JV Hartel, T Vinh, JC Fanburg-Smith - Davis Memorial Hospital, Elkins, WV; AFIP, Washington, DC; Covenant Medical Center, Waterloo, IA
Add
40 Mammary Adenomyoepitheliomas May Feature Basal/Spindle Cells with an Uncommitted Epithelial Phenotype: Biologic and Diagnostic Implications (217)
BC Ho, IO Ellis - Nottingham City Hospital, Nottingham, United Kingdom; Tan Tock Seng Hospital, Singapore, Singapore
Add
41 Histopathology of the Male Breast: Eleven Years Experience of the Vanderbilt Breast Consultation Service (306)
ME Sanders, SA Manning, JA Smith, JF Simpson, DL Page - Vanderbilt University, Nashville, TN
Add
42 Molecular Classification of Male Breast Cancer Using Immunohistochemistry (135)
G Al-Saati, KC Jensen - King Saud University, Riyadh, Saudi Arabia; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA; Stanford University Hospital, Stanford, CA
Add
43 Epidermal Growth Factor Receptors and Topoisomerase II Alpha in Primary Adenoid Cystic Carcinomas of the Breast (333)
S Vranic, S Frkovic-Grazio, N Bilalovic, JP Palazzo, Z Gatalica - Creighton University School of Medicine, Omaha, NE; Institute of Oncology, Ljubljana, Slovenia; University Clinical Center, Sarajevo, Bosnia and Herzegowina; Jefferson Medical Center, Philadelphia, PA
Add
44 Hematolymphoid Neoplasms of the Breast: A Clinicopathologic Study of 58 Cases (320)
MM Stoecker, E Wang - Duke University Medical Center, Durham, NC
Add
45 Breast Carcinoma Following Treatment of Hodgkin Lymphoma: A Study of 31 Patients (205)
A Goyal, C Mies - Hospital of the University of Pennsylvania, Philadelphia, PA
Add
46 Histological Grading of Breast Carcinoma: Variability between Breast Subspecialty Pathologists and General Pathologists (345)
K Woolf, J Wang, X Wang, LM Schiffhauer, DG Hicks, P Tang - University of Rochester Medical Center, Rochester, NY; RTI Health Solutions, Research Triangle Park, NC
Add
47 Markers of Metastatic Breast Cancer: Correlations between GCDFP-15 or Mammaglobin Expression and Tumor Grade, Hormone Receptor, and HER2 Expression (204)
AM Gown, LC Goldstein, PL Kandalaft, HC Hwang, SJ Kussick, CC Tse - PhenoPath Laboratories, Seattle, WA; IMPRIS, Seattle, WA
Add
48 P75/P63; a Novel Immunohistochemical Cocktail Which Is Diagnostically Superior to P63 for the Evaluation of Myoepithelial Cells in Challenging Breast Lesions (178)
SJ Conlon, DE McCrae, SC Chak, SM Moran, FP O'Connell, TJ Browne - Cork University Hospital, Cork, Ireland
Add
49 Mammaglobin Distinguishes Cutaneous Metastasis of Breast Cancer from Primary Cutaneous Adnexal Tumors (331)
ME Vergara, TH McCalmont, YY Chen, JT Rabban - UCSF, San Francisco, CA
Add
50 Beta-Catenin/WNT Signaling Pathway in Fibromatosis, Metaplastic Carcinomas and Phyllodes Tumours of the Breast (198)
FC Geyer, M Lacroix-Triki, K Savage, AH Lee, JS Reis-Filho - ICR, London, United Kingdom; Institut Claudius Regaud, Toulouse, France; Nottingham City Hospital, Nottingham, United Kingdom
Add
51 Reevaluation and Identification of the Best Immunohistochemical Panel for Differentiating Breast Ductal Adenocarcinoma from Pancreatic Adenocarcinoma (254)
H Liu, J Shi, JW Prichard, F Lin - Geisinger Medical Center, Danville, PA
Add
52 Relevance of Multiple Breast Cancer Cell Lines as Models for Breast Cancers (171)
YJ Choi - Yale University School of Medicine, Bridgeport, CT
Add
53 From the Bin to the Gene: Leftovers of Diagnostic Fine Needle Aspiration Cytology Can Be Successfully Used To Perform Gene Expression Profiling of Breast Carcinomas (144)
L Annaratone, C Marchio, I Castellano, D Cantarella, E Allia, G Bussolati, E Medico, A Sapino - University of Turin, Turin, Italy; Institute for Cancer Research and Treatment, Turin, Italy
Add
54 Breast Cancer Molecular Subtype Classification: A Comparison of Three Microarray-Based Single Sample Predictors (338)
B Weigelt, A Mackay, R Natrajan, DS Tan, A Ashworth, JS Reis-Filho - CRUK London Research Institute, London, United Kingdom; ICR, London, United Kingdom
Add
55 Quantitative Gene Expression by RT-PCR in the Special Histologic Subtypes of Estrogen Receptor Positive Invasive Breast Cancer (150)
FL Baehner, D Watson, J Anderson, C Millward, I Chen, S Shak - University of California, San Francisco, San Francisco, CA; GHI, Redwood City, CA
Add
56 A Large-Scale Tissue Microarray Study Confirms the Prognostic Value of P-Cadherin Expression in Breast Cancer and Association with Her2+ and Basal Subtypes (329)
G Turashvili, S McKinney, O Goktepe, S Leung, D Huntsman, S Aparicio - BC Cancer Research Centre, Vancouver, BC, Canada; University of British Columbia, Vancouver, BC, Canada
Add
57 PTEN Loss of Expression Is Not Related with PTEN Promoter Hypermethylation in HER2-Positive Breast Carcinoma (200)
D Giner, L Sanchez-Tejada, FJ Gutierrez-Avino, L Perez-Carbonell, FI Aranda, E Lerma, L Catasus, G Peiro - Hospital General Universitari, Alacant, Spain; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Add
58 Luminal A Versus Luminal B Tumors: Significance of Proliferation Index in ER Positive HER2 Negative Tumors (264)
E Marchetti, D Dabbs, J Yu, S Beriwal, R Bhargava - Magee-Womens Hospital of UPMC, Pittsburgh, PA
Add
59 Cortactin Gene Amplification and Expression in Breast Cancer (259)
MA Lopez-Garcia, FC Geyer, MB Lambros, R Vatcheva, R Natrajan, KK Dedes, JS Reis-Filho - ICR, London, United Kingdom
Add
60 ER/PR and Her2/Neu Correlation between Immunohistochemisty and Gene Expression Profiling in Women with Invasive Breast Cancer (188)
M Dydo, J Shutter - University of South Florida, Tampa, FL
Add
61 PPM1D Overexpression and Gene Amplification in Breast Cancers: A QRT-PCR and Chromogenic In Situ Hybridization Study (249)
MB Lambros, R Natrajan, FC Geyer, MA Lopez-Garcia, K Savage, M Lacroix-Triki, JS Reis-Filho - ICR, London, United Kingdom; Institut Claudius Regaud, Toulouse, France
Add
62 Increased Erythropoietin Receptor Expression Is Associated with Distinct Gene Expression Profile in Human Breast Cancer (290)
Z Rakosy, G Paragh, G Acs - Moffitt Cancer Center, Tampa, FL; Women's Pathology Consultants, Ruffolo Hooper & Associates, Tampa, FL
Add
63 Drosha and Dicer Down-Regulation in Breast Cancer: A QRT-PCR Analysis (274)
R Natrajan, F Geyer, MB Lambros, MA Lopez-Garcia, K Savage, JS Reis-Filho - Institute of Cancer Research, London, United Kingdom; Hospital Universitario Virgen del Rocio, Seville, Spain
Add
64 Calretinin Expression in Poorly Differentiated Breast Carcinomas with an Emphasis on the Basal-Like Subtype (315)
K Singh, H Sidhu, S Mangray, R Tavares, L Noble, M Resnick, R DeLellis, E Yakerewich - Brown University, Providence, RI
Add
65 Expression, Regulation and Function of Myoglobin in Breast Cancer (246)
G Kristiansen, J Hu, D Stiehl, M Rose, J Gerhardt, FR Fritzsche, H Moch, JP Theurillat, E Gnaiger, T Hankeln, TA Gorr, E Dahl - University of Zurich, Zurich, Switzerland; University Hospital of the RWTH Aachen, Aachen, Germany; Medical University of Innsbruck, Innsbruck, Austria; Johannes Gutenberg University Mainz, Mainz, Germany
Add
66 A Comparative Study of p16 Expression in Basal-Like Carcinoma and High-Grade Invasive Ductal Carcinoma of the Breast (158)
OL Bohn, M Fuertes-Camilo, L Navarro, J Saldivar, S Sanchez-Sosa - Christus Muguerza UPAEP University Hospital/Hospital Angeles, Puebla, Mexico
Add
67 Biomarker Expression Can Identify Biologically Distinct Categories of Invasive Breast Cancer (312)
JY Shim, R Zhou, PA Thompson, AM Brewster, JL Murray, ME Edgerton, N Karadag, ML Bondy, A Sahin - MD Anderson Cancer Center, Houston, TX; Arizona Cancer Center, Tucson, AZ
Add